Finally, studies have focused on specific biomarkers and immune cells, and future studies will involve a wider range of biomarkers (e.g., urinary exosomes, IL-6, UCA1) and immune cell subsets (e.g., M2-type macrophages, depleted T cells) to fully assess their role in BC pathogenesis. The gene discussed is IL6; the disease is breast cancer.